permanganate
Sodium permanganate is the inorganic compound used as oxidant and etchant in printed circuitry. Sodium permanganate is a purplish-colored, inorganic salt compound, which is primarily available in aqueous form as a monohydrate. It is miscible in water, ether, ethanol, and liquid chlorine. Sodium permanganate offers a high concentration of permanganate ions. Owing to high solubility in water, it is used for etching of plastic parts, as etching requires a high concentration of permanganate ions. Sodium permanganate is also used for water treatment and soil treatment, as it is capable of degrading phenols, BTEX, chlorinated ethenes, and PAHS and removing hydrogen sulfide. — NCATS
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Earliest trial started May 1, 2004 (NCT00610324)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Unspecified targetOXIDATIVE ENZYME
Oxidative enzyme
Chemistry & pharmacology
SMILES
[O-][Mn](=O)(=O)=O- Mol. weight
- 118.9356 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPotassium permanganate ↗
- NCATS2BL953CCZ2 ↗
- ChEMBLCHEMBL3833305 ↗
Also known as
- en-potab
- permitabs
- potassium permanganate
- potassium permanganate
- potassium permanganate
- potassium permanganate
- potassium permanganate
- potassium permanganate
- potassium permanganate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00610324 | Phase 4 | May 1, 2004 | K.E.M. Hospital Mumbai, King Edward Memorial Hospital, Mumbai |
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| K.E.M. Hospital Mumbai | Academic/Hospital | 1 | 0 | 1 | 2004 |
| King Edward Memorial Hospital, Mumbai | Academic/Hospital | 1 | 1 | 1 | 2004 |